We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years.
- Authors
Bernal, Jamie Lopez; Andrews, Nick; Gower, Charlotte; Stowe, Julia; Tessier, Elise; Simmons, Ruth; Ramsay, Mary
- Abstract
We estimated the risk of death from coronavirus disease 2019 in vaccinated compared with unvaccinated patients. The risk of death was reduced 44% after 1 dose of the Pfizer-BioNTech BNT162b2 vaccine, 55% after 1 dose of the Oxford-Astrazeneca ChAdOx1 vaccine, and 69% after 2 doses of the BNT162b2 vaccine. This is above the protection provided against infection.
- Subjects
ENGLAND; DRUG efficacy; COVID-19; VIRAL vaccines; CONFIDENCE intervals; COVID-19 vaccines; RISK assessment; MESSENGER RNA; SURVIVAL analysis (Biometry); DESCRIPTIVE statistics; KAPLAN-Meier estimator; RESEARCH funding; POLYMERASE chain reaction; OLD age
- Publication
Clinical Infectious Diseases, 2024, Vol 78, Issue 2, p349
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciab881